Subgroup and sensitivity analyses of annualized relapse rate over 2 years in the ADVANCE trial of peginterferon beta-1a in patients with relapsing-remitting multiple sclerosis

Scott D. Newsome, Bernd C. Kieseier, Douglas L. Arnold, Shulian Shang, Shifang Liu, Serena Hung, Guido Sabatella

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Subgroup and sensitivity analyses of annualized relapse rate over 2 years in the ADVANCE trial of peginterferon beta-1a in patients with relapsing-remitting multiple sclerosis'. Together they form a unique fingerprint.

Medicine & Life Sciences